Agilent Can't Get Rival's DNA Patent Ruled Invalid

Law360, Los Angeles (March 10, 2014, 6:44 PM EDT) -- A California federal judge on Friday refused to dismiss Genetic Technologies Ltd.’s allegations that Agilent Technologies Inc. sold a DNA-testing device that infringes GT's genetic analysis patent, ruling the patent did not merely cover a law of nature.

U.S. District Judge Richard Seeborg denied Agilent’s motion to dismiss, which claimed GT's patent was invalid because it was based on an unpatentable natural phenomenon. Agilent said its 2100 Bioanalyzer product couldn't infringe GT's U.S. Patent Number 5,612,179 because the patent only described the natural relationship between so-called...
To view the full article, register now.